Post-approval studies (Phase 4)Ended earlyNCT01512472What this trial is testingFirmagon (Degarelix) Intermittent TherapyWho this might be right forProstate Cancer Recurrent Canadian Urology Research Consortium 144
Testing effectiveness (Phase 2)Active Not RecruitingNCT03753334What this trial is testingEffects of EPA in Men With Biochemical Recurrence or Progression of Prostate Cancer.Who this might be right forProstate Cancer CHU de Quebec-Universite Laval 39
Not applicableEnded earlyNCT04234399What this trial is testingDetermination of the Diagnostic Detection Rate of Axumin (Fluciclovine) Digital PET/CT, Post-prostatectomyWho this might be right forProstatic Neoplasm University of Vermont 22
Not applicableUnknownNCT05048537What this trial is testing18F-FACBC PET/CT and the PSA Kinetics for PCa Patients With Biochemical Recurrence.Who this might be right forBiochemical Relapse Fo Malignant Neoplasm of Prostate National Taiwan University Hospital 20
Large-scale testing (Phase 3)Study completedNCT06235099What this trial is testingCopper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate CancerWho this might be right forProstate CancerProstate AdenocarcinomaBiochemical Recurrence of Malignant Neoplasm of Prostate Curium US LLC 235
Very early researchStudy completedNCT03768349What this trial is testingPSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate CancerWho this might be right forProstate Cancer Mayo Clinic 250
Testing effectiveness (Phase 2)Active Not RecruitingNCT05478239What this trial is testingArtemiCoffee in Patients With Rising PSAWho this might be right forProstate Cancer Zin W Myint 20
Not applicableUnknownNCT01530295What this trial is testingBiochemical Recurrence Rate of Radical Prostatectomy Combined With Neoadjuvant and Adjuvant Chemotherapy in High Risk Prostate CancerWho this might be right forProstate Cancer Hanjong Ahn 70
Testing effectiveness (Phase 2)UnknownNCT02452307What this trial is testingPeptide-specific Vaccination in HLA-A*02 Positive Patients With Biochemical Recurrence After Radical ProstatectomyWho this might be right forRecurrent Prostate Cancer University Hospital Tuebingen 36
Testing effectiveness (Phase 2)Ended earlyNCT00879619What this trial is testingTaxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer PatientsWho this might be right forProstate CancerAdenocarcinoma of the ProstateRecurrent Prostate Cancer+3 more John P. Fruehauf 4
Large-scale testing (Phase 3)Study completedNCT04102553What this trial is testingF-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical RecurrenceWho this might be right forProstate CancerProstate Cancer Recurrent ABX advanced biochemical compounds GmbH 200
Large-scale testing (Phase 3)Study completedNCT00779402What this trial is testingPROvenge Treatment and Early Cancer TreatmentWho this might be right forProstate Cancer Dendreon 176
Large-scale testing (Phase 3)Study completedNCT03353740What this trial is testingGallium-68 PSMA-11 Positron Emission Tomography (PET) Imaging in Patients With Biochemical RecurrenceWho this might be right forProstate Cancer Thomas Hope 346
Early research (Phase 1)Active Not RecruitingNCT06105918What this trial is testingRadioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate CancerWho this might be right forBiochemically Recurrent Prostate CarcinomaProstate Adenocarcinoma Emory University 6
Not applicableLooking for participantsNCT06859203What this trial is testingA Prospective, Bicentric Evaluation of Fluciclovine PET-imaging in Patients with Prior Negative or Inconclusive PSMA-ligand PETWho this might be right forBiochemical Recurrence of Malignant Neoplasm of Prostate Technical University of Munich 94
Not applicableStudy completedNCT01967862What this trial is testingFluorine F 18 Sodium Fluoride PET/CT and Whole Body and Axial MRI in Finding Metastases in Patients With Recurrent Prostate CancerWho this might be right forRecurrent Prostate Cancer City of Hope Medical Center 54
Testing effectiveness (Phase 2)UnknownNCT01883128What this trial is testingFOcal RECurrent Assessment and Salvage TreatmentWho this might be right forProgression of Prostate Cancer University College London Hospitals 177
Large-scale testing (Phase 3)Study completedNCT03822845What this trial is testingEvaluating the Clinical Accuracy of Gallium-68 PSMA PET/CT Imaging in Patients With Biochemical Recurrence of Prostate CancerWho this might be right forProstatic NeoplasmsProstatic Neoplasms, Castration-Resistant Michael Graham PhD, MD 6
Testing effectiveness (Phase 2)Study completedNCT05249127What this trial is testing64Cu-SAR-bisPSMA for Identification of Participants With Recurrence of Prostate Cancer (COBRA)Who this might be right forBiochemical Recurrence of Malignant Neoplasm of Prostate Clarity Pharmaceuticals Ltd 52
Large-scale testing (Phase 3)Study completedNCT04838613What this trial is testingStudy of Diagnostic Performance of [18F]CTT1057 in BCRWho this might be right forProstatic NeoplasmsProstate CancerRecurrence Novartis Pharmaceuticals 190